LUPIN PHARMS FDA Approval ANDA 065130

ANDA 065130

LUPIN PHARMS

FDA Drug Application

Application #065130

Application Sponsors

ANDA 065130LUPIN PHARMS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL400MG0SUPRAXCEFIXIME

FDA Submissions

ORIG1AP2004-02-12
LABELING; LabelingSUPPL4AP2012-01-17
LABELING; LabelingSUPPL16AP2013-03-29STANDARD
LABELING; LabelingSUPPL18AP2016-02-16STANDARD

Submissions Property Types

SUPPL4Null15
SUPPL16Null15
SUPPL18Null15

CDER Filings

LUPIN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65130
            [companyName] => LUPIN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"SUPRAX","activeIngredients":"CEFIXIME","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SUPRAX","submission":"CEFIXIME","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.